Proceedings of the 38th AGM held on 25.09.2026

GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com 25.09.2026 The Manager [Listing] The BSE Limited The Secretary, Listing Department Phiroze jeejeebhoy Towers, Dalal Street, Fort, Mumbai- 400001 Scrip code: 530317 Dear Sirs/Madam, Sub: Summary of proceedings of the 38th Annual General Meeting of the Company held on 25th September, 2026 We wish to inform you that the 38th Annual General Meeting (AGM) of the Company was held on Friday, September 25, 2026 through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”), to transact the businesses as stated in the AGM Notice dated August 31, 2026. In this regard, please find attached the summary of the proceedings of the 38th AGM pursuant to Regulation 30 read with Para A of Part A of Schedule - III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’). The same is also made available on the Company’s website at www.godavaridrugs.com. Request you to kindly take this intimation on record and acknowledge. Thanking You, For Godavari Drugs Limited Venkatesh Achanta Company Secretary & Compliance Officer Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.comCIN:L24230TG1987PLC008016 GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com PROCEEDINGS OF THE 38TH ANNUAL GENERAL MEETING (‘AGM’) OF GODAVARI DRUGS LIMITED HELD ON FRIDAY, SEPTEMBER 25, 2026 AT 3:00 PM (IST) THROUGH VIDEO CONFERENCING / OTHER AUDIO-VISUAL MEANS. The 38th Annual General Meeting of Godavari Drugs Limited (‘the Company’) was held on Friday, September 25, 2026 at 3:00 PM (IST) through video conferencing (‘VC’) or other audio-visual means (OAVM), in compliance with the applicable provisions of the Companies Act, 2013, pursuant to the General Circular No. 03/2025 dated September 22, 2025 issued by the Ministry of Corporate Affairs (MCA), in continuation of its earlier circulars including General Circular No. 09/2024 dated September 19, 2024, and the circular issued by SEBI vide circular no. SEBI/ HO/ CFD/ CFDPoD-2/ P/ CIR/ 2024/ 133 dated October 3, 2024 (“SEBI Circular”) and other applicable circulars and notifications issued (including any statutory modifications or re-enactment thereof for the time being in force and as amended from time to time), companies are allowed to hold AGM through Video Conferencing (VC) or other audio visual means (OAVM), without the physical presence of members at a common venue. The deemed venue for the meeting was the registered office of the Company at 1-8-303/34, S.P. Road, Secunderabad, Telangana - 500003, India. The Company Secretary welcomed the Members to the Meeting and informed the Members that the 38th AGM was being held through video conference in accordance with the Companies Act, 2013 and circulars issued by the MCA and SEBI. In compliance with the provisions of Section 108 of the Companies Act, 2013, Rule 20 of the Companies (Management and Administration) Rules, 2014 and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had provided remote e- voting facility to all the Members as on the cut-off date i.e. Friday, September 18, 2026, to cast the votes on all resolutions as set forth in the AGM notice from Tuesday, September 22, 2026 to Thursday, September 24, 2026 (both days inclusive). He further informed that the remote e-voting facility was also made available during the AGM for the benefit of Members who were present during the Meeting and had not cast their votes earlier through remote e-voting. MEMBERS’ PRESENT 86 Members were present at the meeting through video conferencing or other audio-visual means. Mr. Ghanshyam Jaju, Chairman of the Company chaired the Meeting. In terms of the MCA Circulars and SEBI Circular, the requirement of appointing proxies was not applicable. The requisite quorum being present, the Chairman called the Meeting to order. The Registers as required under the Companies Act, 2013 were available for inspection. Since there was no physical attendance of Members and in compliance with the Circulars issued by the MCA and SEBI, the requirement of appointing proxies was not applicable. All the Directors attended the Meeting through VC from their respective locations. DIRECTORS PRESENT THROUGH VIDEO CONFERENCING: S. Name of the Director Designation Location for VC 1. Mr. Ghanshyam Jaju Non-Executive - Non Godavari Drugs Ltd Independent Director, office, Secunderabad, Chairperson related to Promoter Telangana, 2. Mr. Mukund Kakani Executive Director, Managing Godavari Drugs Ltd Director office, Secunderabad, Telangana, Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.comCIN:L24230TG1987PLC008016 GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com 3. Mr. Mohit Jaju Whole Time Director Godavari Drugs Ltd office, Secunderabad, Telangana, 4. Ms. Shilpa Bung Non-Executive - Independent Hyderabad , Director Telangana 5. Mr. Mahendra Uday Bhalerao Non-Executive - Independent Hyderabad , Director Telangana 6. Mr. Dinesh Udpa Non-Executive - Independent Hyderabad , Director Telangana KEY MANAGERIAL PERSONNEL (KMP): S. Name of the KMP Designation Location for VC 1. Mr. Mohit Jaju Chief Financial Officer Godavari Drugs Ltd Company Secretary and 2. Mr. Venkatesh Achanta office, Secunderabad, Compliance Officer Telangana, BY INVITATION: S. Name of the Officials Designation Location for VC Partner, VSS & Associates, Company Secretaries, 1. Ms. Vidya Harkut Hyderabad, Telangana, Secretarial Auditors and India Scrutinizer for e-Voting With the consent of the Members, the Notice convening the 38th AGM was taken as read. As the Auditors Report on the Financial Statements for the year ended 31st March, 2026, had no qualifications, reservations, observations, adverse remarks or disclaimer, the same was not read by the Company Secretary. The Chairman made his opening remarks, including on the business operations and financial performance of the Company. The Chairman informed that the Board had appointed Ms. CS Vidya Harkut, Practicing Company Secretary (FCS No. 7086 / COP No. 7534) as Scrutinizer to scrutinize the remote e-voting process as well as e-voting at the AGM in a fair and transparent manner. The Chairman then requested the shareholders to express their views, ask questions and seek clarifications, if any. The Chairman along with the other Directors suitably responded to the questions asked by the Shareholders at the Meeting. While responding to the queries of the Members, Mr. Mohit Jaju, Whole-time Director & Chief Financial Officer, informed the Members that the trials at the facility installed for manufacturing of DHDT, an anti-HIV drug intermediate, are almost completed and that the Company expects commercial supplies to commence shortly against orders. Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.comCIN:L24230TG1987PLC008016 GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com The following Resolutions set out in the Notice convening the AGM were put to vote by remote e- voting and e-voting during the Meeting: Sr. Items Resolution Ordinary Business: 1 To receive, consider and adopt the audited standalone financial statements of the Ordinary Company for the financial year ended March 31, 2026 together with the reports of the Board of Directors an [Showing first 8,000 characters — download PDF for full document]